Cleveland Clinic’s enterprise-wide inflammatory bowel disease (IBD) program has entered a new era, combining novel medical and surgical therapies with pioneering research.
Preoperative Pelvic Radiation is Safe, Effective in Patients with IBD and Rectal Cancer
A new study confirms that preoperative pelvic radiation, with or without concurrent chemotherapy, is safe and effective in IBD patients with locally advanced rectal cancer.
Gastrointestinal Research Roundup: Our Latest Findings in IBD, Barrett’s Esophagus
Learn how Cleveland Clinic is advancing gastrointestinal care: Examining the link between IBD and liver disease, predicting progression in Barrett’s esophagus and investigating stem cell therapy for Crohn’s disease.
Timing of Post-IPAA Complications Predicts Long-Term Outcomes
Inflammatory bowel disease patients who undergo ileal pouch-anal anastomosis and whose pouch survives several years without complication are likely to have excellent long-term outcomes, a Cleveland Clinic conditional survival study has found.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Studies Reveal Heightened Liver Disease Rates in IBD Patients
The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
6 Cleveland Clinic Presentations You’ll Want to Catch at DDW 2019
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
Don’t Miss This Stellar CME Opportunity in IBD Management
If you’re looking for the latest insights and leading-edge information on IBD and gastrointestinal endoscopy, you’ll want to attend these upcoming Cleveland Clinic CME events.
The State of Play of Stem Cells in Inflammatory Bowel Disease
Cleveland Clinic colorectal surgeon Amy Lightner, MD, a leading translational researcher and clinical trials director, talks about stem cells’ potential to improve IBD management.
“It Takes a Village” to Provide Exceptional Patient Care
Miguel Regueiro, MD, the recently appointed chair of Cleveland Clinic’s Gastroenterology, Hepatology and Nutrition Department, shares some thoughts on patient care, leadership and the future of healthcare.
How We Improve Conditions for Complex Cases, from Gastroparesis to IBD
Fragmentation of care is a common problem across many gastrointestinal conditions. Learn about three focused programs Cleveland Clinic has developed for complex GI cases.